Additionally, we utilized the TCGA-COAD bulk samples to obtain the same conclusion that TIMP1 and SERF2 contents were elevated in LI patients (Supplementary Fig. 5D). This evidence concerns the gene TIMP1 and colon adenocarcinoma.